Monitlab S.A.

Independent medical laboratory activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2025-09-19
Share capital
10,000,000.00 PLN
Activity description

Monitlab is a diagnostic laboratory specializing in therapeutic drug monitoring (TDM), including posaconazole and voriconazole used in oncology and busulfan used before hematopoietic stem cell transplantation. It offers single-sample measurements and full pharmacokinetic profiles, with results and interpretation within 48 hours. Its laboratory uses an UltiMate 3000 UHPLC chromatograph.

Registered address
pl. Jana Kilińskiego 2, 35-005 Rzeszów, Poland
Email
Social media

Financials

Filing timeliness

1 of 1 financial statements was filed late (for 2025, 20 days late). All were audited by a statutory auditor.

  • 202504/08/2026
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Division · Human health activities5,616 / 6,271
Top 90%
Top 89%
City · Rzeszów2,710 / 3,762
Top 72%
Voivodeship · Podkarpackie8,250 / 10,779
Top 77%
Country · Poland225,187 / 297,069
Top 76%

Results vs industry

Revenue
This companyUSD 45.93kMedianUSD 691.89kAverageUSD 19.79m
Net profit
This companyUSD -178.14kMedianUSD 35.88kAverageUSD 1.18m
Operating costs
This companyUSD 109.07kMedianUSD 615.15kAverageUSD 17.92m
Assets
This companyUSD 2.43mMedianUSD 306.00kAverageUSD 11.31m

Offer

Websites

  • monitlab.plMonitlab S.A. – terapeutyczne monitorowanie leków

Public procurement

The company is the contractor in one public sector contract, worth USD 81.04.

SubjectAmount
Medical services
$81.04

Job offers

The company has its own careers page: monitlab.pl/pl/kariera.

Authorized Representatives

Marek Smolski age 54 – President of the Management Board

Manner of representation

In the case of a multi-member management board, making declarations of will on behalf of the company requires the joint action of two members of the management board or one member of the management board jointly with a commercial proxy.

Supervisory board

Bartosz Augustynowicz age 35 – Supervisory Board Member
Patrycja Belczyńska age 32 – Supervisory Board Member
Małgorzata Nosal age 67 – Supervisory Board Member

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2020-05-22.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–
Aid for SME access to finance — aid for start-ups
–

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Labplus S.A.
AMO Solutions sp. z o.o.
Badamysie.Pl sp. z o.o.
Anchem Laboratorium Analiz Medycznych Nzoz sp. z o.o.
Novazym sp. z o.o.
Centrum Medycyny Klinicznej Dimedical sp. z o.o.
Alldiagnostica sp. z o.o.
Diagnostyka Obrazowa Bydgoszcz sp. z o.o.
Ctin Poland sp. z o.o.
Info-Pat sp. z o.o.

Change history

DateEvent
2025-11-27PKD change
2025-09-19Entered in the register

FAQ

Last updated: 2026-10-21